SCHEMBL16897952

SCHEMBL16897952

CCCC(=O)OSSc1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
EHMT2 Q96KQ7 1/20 0.46
EHMT1 Q9H9B1 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
ALDH1A1 P00352 7/20 0.44
SMN1; SMN2 Q16637 4/20 0.42
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 5/20 0.40
HPGD P15428 3/20 0.40
NPC1 O15118 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PKM P14618 2/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 2/20 0.38
MAPK10 P53779 1/20 0.37
RGS12 O14924 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25399704 0.92 LMNA (0.48) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL29573871 0.89 LMNA (0.46) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL1425231 0.88 LMNA (0.52) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL28254695 0.85 LMNA (0.52) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL28494764 0.79 LMNA (0.57) LMNAEHMT2EHMT1APOBEC3GALDH1A1
Butyric Acid SCHEMBL15845048 0.78 ALDH1A1 (0.61) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL535803 0.77 LMNA (0.50) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL29224770 0.75 LMNA (0.43) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL12893090 0.75 LMNA (0.48) LMNAEHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL28529987 0.75 EHMT2 (0.47) LMNAEHMT2EHMT1APOBEC3GALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113769108-B Conjugates of cysteine engineered antibodies 伊缪诺金公司 2024-11-08 CN disclosed
EP-4366777-A2 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2024-05-15 EP disclosed
WO-2023160376-A1 ANTIBODIES AND VARIANTS THEREOF AGAINST HUMAN B7-H3 NANJING PROBIO BIOTECH CO., LTD. (CN) 2023-08-31 WO disclosed
CN-115850449-A Antibodies and conjugates 苏州智核生物医药科技有限公司 2023-03-28 CN disclosed
EP-4149546-A1 DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF Hunilife Biotechnology, Inc. (TW) 2023-03-22 EP disclosed
WO-2023280227-A2 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2023-01-12 WO disclosed
WO-2021228044-A1 DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF HUNILIFE BIOTECHNOLOGY, INC. (CN) 2021-11-18 WO disclosed
EP-3189082-A1 ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS Birdie Biopharmaceuticals Inc. (KY) 2017-07-12 EP disclosed
EP-3092254-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING HER2 POSITIVE TUMORS Birdie Biopharmaceuticals Inc. (KY) 2016-11-16 EP disclosed
EP-3092255-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING EGFR EXPRESSING TUMORS Birdie Biopharmaceuticals Inc. (KY) 2016-11-16 EP disclosed
EP-3092256-A1 COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY Shanghai Birdie Biotech Inc. (CN) 2016-11-16 EP disclosed
WO-2016034085-A1 ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS BIRDIE BIOPHARMACEUTICALS, INC. (KY) 2016-03-10 WO disclosed
WO-2015103987-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING HER2 POSITIVE TUMORS SHANGHAI BIRDIE BIOTECH, INC. (CN) 2015-07-16 WO disclosed
WO-2015103989-A1 COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY SHANGHAI BIRDIE BIOTECH, INC. (CN) 2015-07-16 WO disclosed
WO-2015103990-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING EGFR EXPRESSING TUMORS SHANGHAI BIRDIE BIOTECH, INC. (CN) 2015-07-16 WO disclosed